These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8862609)

  • 1. Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group.
    Scott WA; Brambilla D; Siwak E; Beatty C; Bremer J; Coombs RW; Farzadegan H; Fiscus SA; Hammer SM; Hollinger FB; Khan N; Rasheed S; Reichelderfer PS
    J Clin Microbiol; 1996 Sep; 34(9):2312-5. PubMed ID: 8862609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free plasma human immunodeficiency virus type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction.
    Coombs RW; Henrard DR; Mehaffey WF; Gibson J; Eggert E; Quinn TC; Phillips J
    J Clin Microbiol; 1993 Aug; 31(8):1980-6. PubMed ID: 8370724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories.
    Jackson JB; Drew J; Lin HJ; Otto P; Bremer JW; Hollinger FB; Wolinsky SM
    J Clin Microbiol; 1993 Dec; 31(12):3123-8. PubMed ID: 8308102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial.
    Fiscus SA; DeGruttola V; Gupta P; Katzenstein DA; Meyer WA; LoFaro ML; Katzman M; Ragni MV; Reichelderfer PS; Coombs RW
    J Infect Dis; 1995 Feb; 171(2):305-11. PubMed ID: 7844365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories.
    Reimann KA; Chernoff M; Wilkening CL; Nickerson CE; Landay AL
    Clin Diagn Lab Immunol; 2000 May; 7(3):352-9. PubMed ID: 10799445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories.
    Yen-Lieberman B; Brambilla D; Jackson B; Bremer J; Coombs R; Cronin M; Herman S; Katzenstein D; Leung S; Lin HJ; Palumbo P; Rasheed S; Todd J; Vahey M; Reichelderfer P
    J Clin Microbiol; 1996 Nov; 34(11):2695-701. PubMed ID: 8897167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality monitoring of HIV-1-infected and uninfected peripheral blood mononuclear cell samples in a resource-limited setting.
    Olemukan RE; Eller LA; Ouma BJ; Etonu B; Erima S; Naluyima P; Kyabaggu D; Cox JH; Sandberg JK; Wabwire-Mangen F; Michael NL; Robb ML; de Souza MS; Eller MA
    Clin Vaccine Immunol; 2010 Jun; 17(6):910-8. PubMed ID: 20200187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes.
    Erice A; Sannerud KJ; Leske VL; Aeppli D; Balfour HH
    J Clin Microbiol; 1992 Feb; 30(2):444-8. PubMed ID: 1537914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories.
    Muyldermans G; Debaisieux L; Fransen K; Marissens D; Miller K; Vaira D; Vandamme AM; Vandenbroucke AT; Verhofstede C; Schuurman R; Zissis G; Lauwers S
    Clin Microbiol Infect; 2000 Apr; 6(4):213-7. PubMed ID: 11168110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of a laboratory developed PCR test for quantitation of HIV-2 viral RNA.
    Jagodzinski LL; Manak MM; Hack HR; Liu Y; Peel SA
    PLoS One; 2020; 15(2):e0229424. PubMed ID: 32109949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.
    Lambert JS; Harris DR; Stiehm ER; Moye J; Fowler MG; Meyer WA; Bethel J; Mofenson LM
    J Acquir Immune Defic Syndr; 2003 Dec; 34(5):512-9. PubMed ID: 14657763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing.
    Lathey JL; Marschner IC; Kabat B; Spector SA
    J Clin Microbiol; 1997 Mar; 35(3):631-5. PubMed ID: 9041402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 detection by nested PCR and viral culture in fresh or cryopreserved postmortem skin: potential implications for skin handling and allografting.
    Gala JL; Vandenbroucke AT; Vandercam B; Pirnay JP; Delferrière N; Burtonboy G
    J Clin Pathol; 1997 Jun; 50(6):481-4. PubMed ID: 9378813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fresh lymphocytes on increased sensitivity of HIV-1 isolation: a multicenter study.
    Farzadegan H; Imagawa D; Gupta P; Lee MH; Jacobson L; Saah A; Grovit K; Rinaldo CR; Polk BF
    J Acquir Immune Defic Syndr (1988); 1990; 3(10):981-6. PubMed ID: 2118952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human immunodeficiency virus (HIV) in naturally infected peripheral blood mononuclear cells: comparison of a standard co-culture technique with a newly developed microculture method.
    Eberlein B; Baur A; Neundorfer M; Jahn G
    Virus Res; 1991 May; 19(2-3):153-61. PubMed ID: 1909827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Nolte FS; Boysza J; Thurmond C; Clark WS; Lennox JL
    J Clin Microbiol; 1998 Mar; 36(3):716-20. PubMed ID: 9508301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples.
    Dyer WB; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd A; Lewin SR
    Clin Vaccine Immunol; 2007 Jan; 14(1):52-9. PubMed ID: 17050740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious decay of human immunodeficiency virus type 1 in plasma.
    Moudgil T; Daar ES
    J Infect Dis; 1993 Jan; 167(1):210-2. PubMed ID: 8418169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay.
    Gürtler L; Mühlbacher A; Michl U; Hofmann H; Paggi GG; Bossi V; Thorstensson R; G-Villaescusa R; Eiras A; Hernandez JM; Melchior W; Donie F; Weber B
    J Virol Methods; 1998 Nov; 75(1):27-38. PubMed ID: 9820572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
    Marozsan AJ; Fraundorf E; Abraha A; Baird H; Moore D; Troyer R; Nankja I; Arts EJ
    J Virol; 2004 Oct; 78(20):11130-41. PubMed ID: 15452233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.